Aclaris Therapeutics (ACRS) Stock Chart & Stock Price History → Things Are Not Normal in America – Here’s What to Do (From Stansberry Research) (Ad) Free ACRS Stock Alerts $1.23 +0.01 (+0.41%) (As of 01:51 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Aclaris Therapeutics Stock Price Performance5 Day Performance-9.93%1 Month Performance+2.94%3 Month Performance-0.41%6 Month Performance-75.10%Year-To-Date Performance+16.67%1 Year Performance-85.21% Receive ACRS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aclaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad American Hartford Gold GroupTrump Asset Seizure Threat Alert: Could Your Savings Be Next?Trump Asset Seizures Threat A Warning For 401K Owners?Request Your FREE WEALTH PROTECTION GUIDE ACRS Stock Chart for Thursday, May, 9, 2024 ACRS Chart by TradingView Aclaris Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$1.34$1.22-8.96%$1.35$1.201.23 million shs$86.94 million05/07/2024$1.31$1.34+2.29%$1.36$1.28726,991 shs$95.49 million05/06/2024$1.36$1.31-3.68%$1.40$1.26631,436 shs$93.35 million05/03/2024$1.31$1.36+3.82%$1.40$1.31688,182 shs$96.91 million05/02/2024$1.26$1.31+3.97%$1.31$1.21788,414 shs$93.35 million05/01/2024$1.21$1.26+4.13%$1.27$1.21979,115 shs$89.79 million Get the Latest News and Ratings for ACRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aclaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$1.22$1.21-0.82%$1.23$1.19801,165 shs$86.23 million04/29/2024$1.20$1.22+1.67%$1.22$1.18654,770 shs$86.94 million04/26/2024$1.19$1.20+0.84%$1.20$1.16445,216 shs$85.12 million04/25/2024$1.17$1.19+1.71%$1.23$1.141.63 million shs$84.41 million04/24/2024$1.22$1.17-4.10%$1.24$1.141.44 million shs$82.98 million04/23/2024$1.22$1.22$1.25$1.22636,944 shs$86.54 million04/22/2024$1.24$1.22-1.61%$1.25$1.21663,116 shs$86.54 million04/19/2024$1.23$1.24+0.81%$1.25$1.21579,779 shs$87.95 million04/18/2024$1.23$1.23$1.26$1.21645,828 shs$87.24 million04/17/2024$1.22$1.23+0.82%$1.25$1.21562,986 shs$87.24 million04/16/2024$1.21$1.22+0.83%$1.26$1.21676,467 shs$86.54 million04/15/2024$1.21$1.21$1.30$1.211.07 million shs$85.83 million04/12/2024$1.22$1.21-0.82%$1.23$1.19871,119 shs$85.83 million04/11/2024$1.16$1.22+5.17%$1.24$1.16631,494 shs$86.53 million04/10/2024$1.19$1.16-2.52%$1.22$1.15614,003 shs$82.27 million04/09/2024$1.19$1.19$1.24$1.19333,080 shs$84.41 million04/08/2024$1.19$1.19$1.22$1.18624,529 shs$84.41 million04/05/2024$1.23$1.19-3.25%$1.24$1.18531,507 shs$84.41 million04/04/2024$1.25$1.23-1.60%$1.29$1.22622,891 shs$87.24 million04/03/2024$1.22$1.25+2.46%$1.27$1.21733,089 shs$88.66 million04/02/2024$1.26$1.22-3.17%$1.26$1.19731,668 shs$86.54 million04/01/2024$1.24$1.26+1.61%$1.32$1.23721,484 shs$89.37 million03/29/2024$1.24$1.24$1.29$1.24599,308 shs$87.95 million03/28/2024$1.26$1.24-1.59%$1.29$1.24598,346 shs$87.95 million03/27/2024$1.18$1.26+6.78%$1.29$1.191.29 million shs$89.37 million03/26/2024$1.16$1.18+1.72%$1.21$1.16716,237 shs$83.70 million03/25/2024$1.15$1.16+0.87%$1.21$1.15586,363 shs$82.27 million03/22/2024$1.20$1.15-4.17%$1.21$1.13548,647 shs$81.57 million03/21/2024$1.19$1.20+0.84%$1.29$1.16989,344 shs$85.12 million03/20/2024$1.15$1.19+3.48%$1.22$1.12793,792 shs$84.41 million03/19/2024$1.15$1.15$1.19$1.15434,460 shs$81.57 million03/18/2024$1.17$1.15-1.71%$1.20$1.14865,557 shs$81.57 million03/15/2024$1.15$1.17+1.74%$1.22$1.121.16 million shs$82.99 million03/14/2024$1.25$1.15-8.00%$1.27$1.112.04 million shs$81.57 millionThings Are Not Normal in America – Here’s What to Do (Ad)Get Out of the Dollar Before May 15 A Wall Street legend and our friend has just warned 896,000 Americans to prepare for May 15.This could be your solution.03/13/2024$1.22$1.25+2.46%$1.32$1.22834,709 shs$88.66 million03/12/2024$1.29$1.22-5.43%$1.43$1.21965,857 shs$86.54 million03/11/2024$1.41$1.29-8.51%$1.45$1.281.45 million shs$91.49 million03/08/2024$1.35$1.41+4.44%$1.48$1.341.20 million shs$100.01 million03/07/2024$1.44$1.35-6.25%$1.45$1.33850,045 shs$95.76 million03/06/2024$1.27$1.44+13.39%$1.51$1.322.06 million shs$102.14 million03/05/2024$1.25$1.27+1.60%$1.30$1.241.37 million shs$90.08 million03/04/2024$1.24$1.25+0.81%$1.29$1.22933,908 shs$88.66 million03/01/2024$1.19$1.24+4.20%$1.25$1.191.51 million shs$87.95 million02/29/2024$1.19$1.19$1.27$1.193.11 million shs$84.24 million02/28/2024$1.20$1.19-0.83%$1.27$1.191.95 million shs$84.24 million02/27/2024$1.21$1.20-0.83%$1.37$1.162.82 million shs$84.95 million02/26/2024$1.19$1.21+1.68%$1.25$1.20859,100 shs$85.66 million02/23/2024$1.21$1.19-1.65%$1.24$1.17720,578 shs$84.24 million02/22/2024$1.20$1.21+0.83%$1.27$1.19954,572 shs$85.66 million02/21/2024$1.21$1.20-0.83%$1.25$1.17585,543 shs$84.95 million02/20/2024$1.19$1.21+1.68%$1.23$1.132.29 million shs$85.66 million02/19/2024$1.19$1.19$1.25$1.161.15 million shs$84.24 million02/16/2024$1.23$1.19-3.25%$1.24$1.171.15 million shs$84.25 million02/15/2024$1.22$1.23+0.82%$1.27$1.211.45 million shs$87.07 million02/14/2024$1.17$1.22+4.27%$1.26$1.16756,611 shs$86.36 million02/13/2024$1.23$1.17-4.88%$1.22$1.161.45 million shs$82.82 million02/12/2024$1.23$1.23$1.27$1.21957,732 shs$87.07 million02/09/2024$1.18$1.23+4.24%$1.26$1.181.04 million shs$87.07 million02/08/2024$1.06$1.18+11.32%$1.20$1.061.12 million shs$83.53 million Related Companies: Reviva Pharmaceuticals Stock Chart Milestone Pharmaceuticals Stock Chart Hookipa Pharma Stock Chart Assertio Stock Chart vTv Therapeutics Stock Chart Chimerix Stock Chart Oncolytics Biotech Stock Chart Genelux Stock Chart ProPhase Labs Stock Chart Q32 Bio Stock Chart Receive ACRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aclaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ACRS) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange348 million Americans lives to END as we know it?The Oxford ClubThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclaris Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.